title: Structure-activity relationships for a series of compounds that inhibit aggregation of the Alzheimer's peptide, Aβ42.
abstract: Inhibiting aggregation of the amyloid-beta (Aβ) peptide may be an effective strategy for combating Alzheimer's disease. As the high-resolution structure of the toxic Aβ aggregate is unknown, rational design of small molecule inhibitors is not possible, and inhibitors are best isolated by high-throughput screening. We applied high-throughput screening to a collection of 65,000 compounds to identify compound D737 as an inhibitor of Aβ aggregation. D737 diminished the formation of oligomers and fibrils, and reduced Aβ42-induced cytotoxicity. Most importantly, D737 increased the life span and locomotive ability of transgenic flies in a Drosophila melanogaster model of Alzheimer's disease (J Biol Chem, 287, 2012, 38992). To explore the chemical features that make D737 an effective inhibitor of Aβ42 aggregation and toxicity, we tested a small collection of eleven analogues of D737. Overall, the ability of a compound to inhibit Aβ aggregation was a good predictor of its efficacy in prolonging the life span and locomotive ability of transgenic flies expressing human Aβ42 in the central nervous system. Two compounds (D744 and D830) with fluorine substitutions on an aromatic ring were effective inhibitors of Aβ42 aggregation and increased the longevity of transgenic flies beyond that observed for the parent compound, D737.
authors.affiliation: Department of Chemistry, Princeton University, Princeton, NJ, 08544, USA.
authors.forename: Angela F
authors.initials: AF
authors.lastname: McKoy
authors.forename: Jermont
authors.initials: J
authors.lastname: Chen
authors.forename: Trudi
authors.initials: T
authors.lastname: Schupbach
authors.forename: Michael H
authors.initials: MH
authors.lastname: Hecht
mesh_terms: D000375:Aging / Q000187:drug effects / Q000235:genetics; D000544:Alzheimer Disease / Q000188:drug therapy; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors*; D000818:Animals; D030801:Animals, Genetically Modified; D004331:Drosophila melanogaster / Q000187:drug effects / Q000235:genetics; D057166:High-Throughput Screening Assays / Q000379:methods; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000037:antagonists & inhibitors*; D051381:Rats; D054852:Small Molecule Libraries / Q000737:chemistry* / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D018675:Toxicity Tests
chemical_list: D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; D054852:Small Molecule Libraries; C075222:amyloid beta-protein (1-42)
keywords: amyloid-beta aggregation inhibitors; biologic screening; chemical biology; chemical structure; drug discovery
references.citation: Annu Rev Pharmacol Toxicol. 2003;43:545-84
references.pmid: 12415125
references.citation: Nat Chem. 2012 Nov;4(11):927-33
references.pmid: 23089868
references.citation: Phys Chem Chem Phys. 2010 May 14;12(18):4543-51
references.pmid: 20428531
references.citation: Chem Biol Drug Des. 2006 Jan;67(1):27-37
references.pmid: 16492146
references.citation: J Biol Chem. 2007 Apr 6;282(14):10311-24
references.pmid: 17284452
references.citation: Biochemistry. 2006 Jan 17;45(2):498-512
references.pmid: 16401079
references.citation: Science. 2003 Apr 18;300(5618):486-9
references.pmid: 12702875
references.citation: Protein Sci. 2005 Jan;14(1):1-12
references.pmid: 15576561
references.citation: J Pept Sci. 2001 May;7(5):227-49
references.pmid: 11428545
references.citation: Science. 2005 Jan 14;307(5707):262-5
references.pmid: 15653506
references.citation: Nat Rev Drug Discov. 2010 May;9(5):387-98
references.pmid: 20431570
references.citation: PLoS One. 2010 Jun 14;5(6):e11101
references.pmid: 20559435
references.citation: Proc Natl Acad Sci U S A. 2008 May 20;105(20):7159-64
references.pmid: 18480256
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16742-7
references.pmid: 12481027
references.citation: Pharmacol Rev. 2011 Jun;63(2):411-36
references.pmid: 21415126
references.citation: Science. 2012 Mar 9;335(6073):1228-31
references.pmid: 22403391
references.citation: Elife. 2013 Jul 16;2:e00857
references.pmid: 23878726
references.citation: Sci Transl Med. 2011 Nov 30;3(111):111cm33
references.pmid: 22133718
references.citation: J Am Chem Soc. 2010 Dec 1;132(47):17015-22
references.pmid: 21062056
references.citation: Trends Pharmacol Sci. 2013 May;34(5):261-6
references.pmid: 23582316
references.citation: Science. 1992 Apr 10;256(5054):184-5
references.pmid: 1566067
references.citation: J Biol Chem. 1999 Sep 3;274(36):25945-52
references.pmid: 10464339
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: J Neurochem. 2007 Jun;101(5):1172-84
references.pmid: 17286590
references.citation: Nature. 2002 Apr 4;416(6880):535-9
references.pmid: 11932745
references.citation: Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
references.pmid: 17245412
references.citation: Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5468-73
references.pmid: 23513222
references.citation: Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9
references.pmid: 3159021
references.citation: Nature. 2006 Mar 16;440(7082):352-7
references.pmid: 16541076
references.citation: J Biol Chem. 2012 Nov 9;287(46):38992-9000
references.pmid: 22992731
references.citation: Biochemistry. 2007 Jul 31;46(30):8850-60
references.pmid: 17595112
references.citation: Physiol Rev. 2001 Apr;81(2):741-66
references.pmid: 11274343
references.citation: Ann Neurol. 1999 Dec;46(6):860-6
references.pmid: 10589538
references.citation: Protein Pept Lett. 2004 Jun;11(3):213-28
references.pmid: 15182223
references.citation: Brain. 2006 Nov;129(Pt 11):2840-55
references.pmid: 17018549
references.citation: Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18349-54
references.pmid: 19015532
references.citation: Neuroscience. 2005;132(1):123-35
references.pmid: 15780472
references.citation: Trends Pharmacol Sci. 1991 Oct;12(10):383-8
references.pmid: 1763432
references.citation: ACS Chem Biol. 2006 Aug 22;1(7):461-9
references.pmid: 17168524
references.citation: J Mol Biol. 2002 Jun 21;319(5):1279-90
references.pmid: 12079364
references.citation: Chem Biol Drug Des. 2007 Sep;70(3):206-15
references.pmid: 17718715
references.citation: Nat Biotechnol. 1999 Jul;17(7):691-5
references.pmid: 10404163